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RESUMO
Sarcopenia é caracterizada por uma diminuição generalizada e progressiva da força, massa e função muscular com o envelhecimento. 
Recentemente, a determinação genética tem sido associada com a massa muscular e força muscular em idosos. Estes dois fenótipos 
de risco são os mais comumente reconhecidos e estudados em relação à sarcopenia, com hereditariedade variando de 30 a 85% 
para a força muscular e 45-90% para a massa muscular. É bem conhecido que o desenvolvimento e manutenção da massa muscular 
na idade adulta reduz o risco de desenvolver sarcopenia e conduz a um envelhecimento saudável. Por isso, é importante identificar 
quais os fatores genéticos que interagem com o envelhecimento e, em particular, com a resposta músculo-esquelética ao exercício.
Esta revisão destina-se a resumir os estudos mais importantes e representativos sobre a possível associação entre determinados 
polimorfismos genéticos e fenótipos musculares nas populações mais velhas. Os aspetos nutricionais serão discutidos, incluindo o 
papel que o exercício pode ter sobre a redução dos efeitos negativos deste fenômeno. Alguns resultados são inconsistentes e desta 
forma é necessária uma maior replicação subjacente à sarcopenia, com amostras maiores e em diferentes ciclos da vida, especial-
mente no tipo e nível de atividade física. No futuro, acreditamos que mais progressos na compreensão da etiologia genética e as 
vias metabólicas vai fornecer informações valiosas sobre importantes mecanismos biológicos envolvidos na fisiologia muscular. Isto 
irá permitir um melhor reconhecimento dos indivíduos com maior risco e uma maior capacidade de enfrentar adequadamente essa 
condição debilitante.
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ABSTRACT
Sarcopenia is characterized by a progressive generalized decrease of skeletal muscle mass, strength and function with aging. Recent-
ly, the genetic determination has been associated with muscle mass and muscle strength in elderly. These two phenotypes of risk are 
the most commonly recognized and studied for sarcopenia, with heritability ranging from 30 to 85% for muscle strength and 45-90% for 
muscle mass. It is well known that the development and maintenance of muscle mass in early adulthood reduces the risk of developing 
sarcopenia and leads to a healthy aging. For that reason it seems important to identify which genetic factors interact with aging and in 
particular with the musculoskeletal response to exercise in such individuals.
This review is designed to summarize the most important and representative studies about the possible association between certain 
genetic polymorphisms and muscle phenotypes in older populations. Also we will focuses on nutrition and some concerns associated 
with aging, including the role that exercise can have on reducing the negative effects of this phenomenon. Some results are inconsis-
tent between studies and more replication studies underlying sarcopenia are needed, with larger samples and with different life cycles, 
particularly in the type and level of physical activity throughout life. In future we believe that further progress in understanding the ge-
netic etiology and the metabolic pathways will provide valuable information on important biological mechanisms underlying the muscle 
physiology. This will enable better recognition of individuals at higher risk and the ability to more adequately address this debilitating 
condition.
Keywords: Aging; Exercise; Muscle, Skeletal; Nutritional Requirements; Sarcopenia.
INTRODUCTION
 Sarcopenia is characterized by a decline in muscle 
mass and strength with increasing age. Currently, this is a 
problem in elderly people because it contributes to reduce 
the capacity for independent living. Hospitalization and falls 
often results in further disease atrophy and a decline in 
physical performance that results in a loss of autonomy.1 
Complications resulting from falls constitute the sixth cause 
of death in older people.2 As a part of normal aging, muscle 
mass is reduced by approximately one-third between the 
ages of 50 and 80 years. Although it is possible to increase 
muscle mass and bone density after the fifth decade. How-
ever, prevention should be the main concern because is 
difficult to regain muscle tissue after several quantities are 
lost. For that reason, the increase and maintenance of mus-
cle mass in early adulthood reduces the risk of developing 
sarcopenia and leads to a healthy aging.2
 It is also important to determine the genetic factors that 
interact with aging and thus modulate the functional ca-
pacity and muscle phenotypes in older adults.3 It is clini-
cally relevant, the identification of “unfavorable” genotypes 
associated with sarcopenia.4 Special emphasis has been 
placed on two polymorphisms that have been most ex-
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tensively studied, i.e., the angiotensin converting enzyme 
gene (ACE) I/D and the alpha-actinin-3 (ACTN3) R577X.5 
Although the published studies indicate that hereditability 
is an important genetic contribution to individual variability 
in muscle phenotypes among elderly people, but the pub-
lished data on specific gene variants are controversial.5-7
 Furthermore, with increasing age it seems essential the 
participation in regular resistance exercise programs fo-
cused on strength and power exercises, benefiting muscle 
anabolism, an effect that can be enhanced if the exercise 
is followed by a nutrition rich in proteins.8 To achieve maxi-
mum benefit, preventative strategies for sarcopenia should 
ideally begin before the fourth decade of life and continue 
long-term.9 This review article describes some of these pre-
ventative strategies.
Etiology of Sarcopenia
 The etiology of sarcopenia is not clearly understood, 
however several mechanisms have been proposed. Age-
ing is associated with quantity and quality of muscle tissue 
reductions.2 Usually sarcopenia is defined by determining 
cut-off measures of skeletal muscle mass below in which 
there is evidence of functional decline or characterized by 
values two or more standard deviations below the young 
adult mean. Janssen, et al.10 characterized values of cut-off 
measures of skeletal muscle mass by 5,76 - 6,75 kg/m2 and 
8,51 - 10,75 kg/m2 for women and men, respectively. These 
values correspond to the risk of disabilities of muscle func-
tion during everyday activities. Social and financial costs 
associated with such disability have been increasing in the 
past decades; therefore strategies for preventing sarcope-
nia are of considerable importance. However, prevention 
requires an understanding of how it develops. 
 A group of mechanisms are involved in sarcopenia, 
namely the reduction in the number and size of type I and 
II fibers, decrease in the number of motor units, accumu-
lation of oxidative products, reduced activation of satellite 
cells and also reduced excitation–contraction coupling.11 
Furthermore the reduction of anabolic hormones (testos-
terone, estrogen, growth hormone and insulin like growth 
factor-1), increasing inflammatory activity and inadequate 
nutrition and inactivity also contribute substantially to the 
development of age-related sarcopenia. 
Muscle Tissue
 The structure of muscle changes in older people have 
been well-described.12 One of the effects of aging is the 
involuntary loss of muscle mass, strength and function.13 
Nevertheless, aging is also characterized by a gradual loss 
of motor neurons, due to apoptosis, high levels of circulat-
ing cytokines (TNF-α and TNF-β) and reduced signaling 
growth factors. Autopsies in the vastus lateralis muscle 
have shown that up to 90 years, there is a reduction by 50% 
in type I and II fibers per decade, when compared to young 
individuals. Histochemical studies conclude that the reduc-
tion and atrophy occurs mainly in type II muscle fibers with 
age.14 This reduces the excitation–contraction coupling, af-
fecting muscle function with increasing age.15 Indeed, in an 
attempt to minimize fiber loss, collaterals from the type I 
motor neurons expand to some of the denervated type II 
fibers.16 Therefore, the muscle tissue tends to lose its con-
figuration, affecting the muscular system (disorders of myo-
filaments and Z-lines) and mechanisms (reduced satellite 
cell activation/proliferation and changes to mitochondrial 
function of muscle cells), which decreases muscle perfor-
mance (reduction of maximum muscle strength and power). 
This will increase the disabilities and functional capacity for 
everyday tasks will also be affected reducing the quality of 
life and decreasing longevity.
ACE and ACTN3 genes and their association with mus-
cle phenotypes 
 A wide range of human phenotypes (e.g., muscle 
strength and bone structure) influence muscle function 
and result in a complex interaction between different sys-
tems: anatomic, biochemical and physiological. About 20 
000 genes defines each of us as human beings.4 However, 
there is substantial variation among individuals and that can 
be seen from replicating of gene sequences, or changes 
in base pairs (individual mutations if frequency < 1% and 
polymorphisms if single nucleotide > 1% frequency). Some 
polymorphisms can significantly affect muscle structure, the 
functional performance and even the response to exercise 
training. One potential candidate gene is the Angiotensin 
Converting Enzyme (ACE) gene. ACE gene is located at 
C17 (17q23.3) and has 25 exons resulting in an mRNA 
with 4022 nucleotides and a protein with 1306 amino acids 
(ENSG00000159640) (http://www.ncbi.nlm.nih.gov/SNP//
snp_ref.cgi?locusId=1636). Multiple alternatively spliced 
transcript variants encoding different isoforms have been 
identified.17 ACE has a key role on the endocrine rennin-an-
giotensin system and is responsible for catalyzing the con-
version of angiotensin I into angiotensin II. Research has 
centered on an insertion–deletion (I/D-allele) polymorphism 
in intron 16, which is characterized by the presence (I-al-
lele) or absence (D-allele) of a 287 bp Alu repeat sequence 
with 535 SNPs. This result in three genotypes: II, DD and 
ID. In Caucasians, the genotype frequency is approximately 
25%, 25% and 50%, respectively.18 However, there is some 
evidence of a different distribution in other racial groups.19
 In cross-sectional studies, the D allele has been as-
sociated with subjects with higher values of muscle mass, 
volume and strength,20,21 while other studies found no as-
sociation.22 The possibility that the DD genotype may be 
associated with a greater proportion of fast twitch fibers 
could explain the possible influence of the ACE D allele 
upon strength/ power, particularly at high velocities tasks.21 
Besides, the II genotype confers some disadvantage in 
functional tasks and, therefore, may correspond to a lower 
muscle performance. 
 Another candidate gene, ACTN3, is located at C11 
(11q13.1) and has 21 exons resulting in an mRNA with 
3084 nucleotides and a protein with 944 amino acids 
(ENSG00000248746) (http://www.ncbi.nlm.nih.gov/SNP//
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snp_ref.cgi?locusId=89). This gene expression is limited 
to skeletal muscle and is localized to the Z-disc, where it 
helps to anchor the myofibrillar actin filaments.23 Variations 
in ACTN3 gene can explain individual variability in muscle 
phenotypes by a substitution of arginine at amino acid resi-
due 577 (R-allele) with a premature stop codon (X-allele). 
Judson, et al.24 showed that functional ACTN3 R577X geno-
type represents a genetic risk factor in older women and re-
ported a strong association between R577X genotype with 
increased risk of falling (10% - 61%). Clarkson, et al.25 and 
Walsh, et al.26 also found that women with the XX genotype 
had lower strength in the elbow flexors and knee extensors 
compared with individuals with genotype RR. Thus alpha-
actinin-3 577X may induces muscle weakness and some 
influence in responses to muscle damaging exercise. How-
ever, it is necessary to develop and reproduce more studies 
in the elderly people to strengthen these sentences. Future 
studies should consider the association between muscle 
phenotypes in this population and complex gene-gene and 
gene-environment interactions.
PREVENTION OF SARCOPENIA 
Nutrition 
 A variety of hormonal changes that contribute to the 
loss of muscle mass is observed during the aging process. 
The body weight and consequently the body mass index 
(BMI) tend to decline after ages of 50 - 60 years.27 The 
weight guidelines for body mass index in older people is 
in the range of 27 – 30 kg/m2 and for younger individuals 
is between 18,5 - 25 kg/m2 and when is considered ideal 
weight for older subjects this may already be at malnutri-
tion and sarcopenia risk.10 Besides, the decline in food in-
take in older persons has been termed “anorexia of age-
ing”.27 In older obese, weight loss should be achieved in a 
way that preserves lean tissue. Older subjects also reduce 
their nutrition and meals by quantity in food intake, espe-
cially dietary protein.28 However, the quantities of protein 
intake in recommended daily allowance may be inadequate 
for exercising subjects.8 However, the effect of the protein 
supplement is not always statistically significant for all ex-
ercises.8,28 Comparatively, creatine supplementation may 
enhance the increase in lean mass but this also has been 
shown only in some exercises8. Thus, the inclusion of an 
exercise program for older people that includes strength 
and aerobic exercises may include simultaneous ingestion 
of protein, calcium and vitamin D. Nutritional interventions, 
as obtaining nutrients from natural food (soybeans, lentils, 
beef, peanuts, salami and salmon) are also potential means 
for the prevention and treatment of sarcopenia.29
Exercise Training
 The best way of preventing sarcopenia appears to be by 
maintaining a regular exercise program.9 Strength exercise 
has been suggested as the preferred strategy to attenu-
ate and reverse the age-related loss of muscle mass and 
function.16 Multiple studies have demonstrated that acute 
resistance exercise increases myofibrillar muscle protein 
synthesis in older adults.16,30 Recent studies have shown 
that the increase in muscle mass and myonuclear content 
in response to strength exercise is accompanied by an in-
crease in number and activation of satellite cells.31 It has 
also been associated with improvements in aerobic capac-
ity (VO2max), improved performance on daily tasks, such as 
climbing stairs, rising from a chair and even walking.32
 As the area of strength-training investigation progress-
es, some scientists are trying to identify the best exercise 
programs for this population, while others continue their 
research in determining what exercise prescription will con-
fer the most benefits for older adults. Currently, it seems 
generally agreed that the benefits of strength training can 
be achieved with low intensities of 50% of one repetition 
maximum (1RM) and not only in greater intensities (to 80% 
of 1RM). Indeed, a markedly lower capacity for concentric 
contractions may result in decline in performance, particu-
larly in tasks where rapid movements are essential (counter-
acting a forward fall, climbing steps or crossing the road).15 
Nevertheless, early studies evaluating whether resistance 
training interventions could increase especially lower ex-
tremity muscle in older people.15,33 Thus, recent random-
ized trials in both men and women, have been designed to 
maximize muscle performance generally and have demon-
strated that high velocity power training is well tolerated and 
effectively.15 (Table 1) However, the efficacy and feasibility 
of high-velocity power training in older adults with chronic 
conditions (osteoarthritis and/or osteoporosis), remains 
uncertain. Aerobic exercise also helps to delay age-related 
decline. Although, depending on its type and intensity, aero-
bic exercise seems to have quite minor beneficial effects to 
prevent the aging effects in muscle system.34
CONCLUSION
 There is a need to develop strategies to prevent sar-
copenia in both men and women in order to prevent loss 
of muscle mass and functionality with aging. Further the 
progress to understanding the genetic etiology of sarco-
penia will provide valuable mechanisms that will improve 
the ability to recognize individuals at risk. Current research 
has suggested that the optimal intervention program should 
include predominantly resistance exercises (strength train-
ing), complemented with some aerobic stimuli. Besides, an 
adequate nutrition is essential to obtain all benefits from re-
sistance training.
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